Innovation Pharmaceuticals Inc (CTIX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CTIX quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Innovation Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Jun 30 2022) (Jun 30 2021) (Jun 30 2020) (Jun 30 2019)
Assets
Cash & cash equivalent1.52
Security Deposit0.08
Cash & Short-term Investments1.00
Deferred Costs, Current AS0.00
Prepaid Expense And Other Assets Current0.12
Total Current Assets1.71
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Long-term investments3.81
Other Assets, Noncurrent1.00
Patents Net2.00
Patents Net2.00
Total Assets7.52
Liabilities
Accounts Payable, Current AC2.99
Accrued Liabilities, Current AC0.07
Convertible Notes Payable, Current NO0.21
Other Liabilities, Current1.75
Total Current Liabilities5.02
Total Long-term Debt0.00
Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs0.00
Other liabilities, Noncurrent0.46
OperatingLeaseLiabilityNoncurrent0.00
Accrued Dividend Series B Five Convertibles Preferred Stock0.00
Operating Lease Liability Current0.06
Total Liabilities5.48
Stockholders' Equity
Common Stock Value0.05
Treasury Stock Value-2.25
Additional Paid In Capital Common Stock129.57
Retained Earnings / Accumulated Deficit-125.33
Other Equity0.00
Common Stockholder's Equity2.04
Total Stockholder's Equity2.04
Liabilities & Stockholder's Equity7.52
4 historic quarters locked

Sign in to unlock the full Innovation Pharmaceuticals Inc balance sheet history.

About Innovation Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-23-008688

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.